Search
Patexia Research
Case number 3:18-cv-17518

VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. PERRIGO PHARMA INTERNATIONAL DAC et al > Documents

Date Field Doc. No.Description (Pages)
Nov 8, 2022 1 Complaint* (1)
Feb 14, 2019 N/A Terminated Case (0)
Docket Text: ***Civil Case Terminated. (mps)
Feb 14, 2019 8 Stipulation and Order (4)
Docket Text: STIPULATED CONSENT JUDGMENT AND INJUNCTION. Signed by Judge Peter G. Sheridan on 2/14/2019. (mps)
Feb 12, 2019 7 Letter (1)
Feb 12, 2019 7 Text of Proposed Order (4)
Feb 12, 2019 7 Main Document (1)
Docket Text: Letter from William P. Deni, Jr. enclosing Stipulated Consent Judgment & Proposed Injunction for execution by Court. (Attachments: # (1) Text of Proposed Order)(DENI, WILLIAM)
Dec 26, 2018 5 AO120 Patent/Trademark Form (1)
Docket Text: AO120 Patent Form filed. (jmh)
Dec 26, 2018 6 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to PERRIGO CO. PLC, PERRIGO PHARMA INTERNATIONAL DAC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh)
Dec 21, 2018 1 Complaint (11)
Dec 21, 2018 N/A Add and Terminate Judges (0)
Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (jjc, )
Dec 21, 2018 1 Exhibit A (18)
Dec 21, 2018 1 Civil Cover Sheet (4)
Dec 21, 2018 1 L. Civ. R. 11.2 Certification (3)
Dec 21, 2018 2 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM)
Dec 21, 2018 3 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM)
Dec 21, 2018 4 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.)
Dec 21, 2018 1 Main Document (11)
Docket Text: COMPLAINT against PERRIGO CO. PLC, PERRIGO PHARMA INTERNATIONAL DAC ( Filing and Admin fee $ 400 receipt number 0312-9262398), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet, # (3) L. Civ. R. 11.2 Certification)(DENI, WILLIAM)
Menu